Nyxoah SA (NASDAQ:NYXH) Short Interest Update

Nyxoah SA (NASDAQ:NYXH) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 160,000 shares, agrowthof29.9% from the July 15th total of 123,200 shares. Approximately0.9% of the shares of the stock are sold short. Based on an average trading volume of 86,300 shares, the days-to-cover ratio is presently 1.9 days. Based on an average trading volume of 86,300 shares, the days-to-cover ratio is presently 1.9 days. Approximately0.9% of the shares of the stock are sold short.

Institutional Trading of Nyxoah

A number of hedge funds and other institutional investors have recently modified their holdings of NYXH. Bank of America Corp DE grew its stake in shares of Nyxoah by 72.4% during the second quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after buying an additional 3,303 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Nyxoah during the second quarter worth $70,000. LPL Financial LLC bought a new stake in shares of Nyxoah during the fourth quarter worth $102,000. Walleye Capital LLC lifted its holdings in shares of Nyxoah by 23.9% during the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock worth $119,000 after purchasing an additional 2,862 shares during the period. Finally, Ameriprise Financial Inc. acquired a new position in shares of Nyxoah during the fourth quarter worth $135,000.

Nyxoah Stock Performance

Shares of NASDAQ:NYXH opened at $6.43 on Friday. The company’s 50 day simple moving average is $7.44 and its 200 day simple moving average is $7.89. The stock has a market capitalization of $219.01 million, a price-to-earnings ratio of -2.80 and a beta of 1.61. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.63 and a quick ratio of 3.35. Nyxoah has a 1 year low of $5.55 and a 1 year high of $11.87.

Nyxoah (NASDAQ:NYXH) last announced its quarterly earnings data on Monday, August 18th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.01). The firm had revenue of $1.58 million during the quarter, compared to the consensus estimate of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 79.18%. As a group, research analysts predict that Nyxoah will post -1.91 EPS for the current fiscal year.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.